Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva®) in Patients with Multiple Sclerosis: An Observational Retrospective Study

Roya Abolfazli*, Mohammad Ali Sahraian, Atefeh Tayebi, Hamidreza Kafi, Sara Samadzadeh*

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

22 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva®) in Patients with Multiple Sclerosis: An Observational Retrospective Study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science